| Full Name | Mary Marlowe |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 18 Years |
| Location | 358 W Main St, Avon, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710216585 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 3601 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Trinity Health Of New England Provider Network Organization Inc | 0941113567 | 621 |
News Archive
Katherine Radek, PhD, of Loyola University Chicago Stritch School of Medicine, has received a prestigious Presidential Early Career Award for Scientists and Engineers.
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
INC Research®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, is pleased to announce that Trusted Process® thought leaders at INC Research were named winners at the 2009 Clinical Research Excellence Awards in London on October 20.
A pre-clinical study led by scientists at Cincinnati Children's demonstrates that in mice the drug barasertib reverses the activation of fibroblasts that cause dangerous scar tissue to build up in the lungs of people with idiopathic pulmonary fibrosis (IPF).
The U.S. Food and Drug Administration today announced the launch of a collaborative study with the National Eye Institute and the U.S. Department of Defense to examine the potential impact on quality of life from Laser-Assisted In Situ Keratomileusis (LASIK), a surgical procedure that uses an eximer laser to permanently change the shape of the cornea.
› Verified 1 days ago
| Entity Name | Trinity Health Of New England Provider Network Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003882812 PECOS PAC ID: 0941113567 Enrollment ID: O20031110000651 |
News Archive
Katherine Radek, PhD, of Loyola University Chicago Stritch School of Medicine, has received a prestigious Presidential Early Career Award for Scientists and Engineers.
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
INC Research®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, is pleased to announce that Trusted Process® thought leaders at INC Research were named winners at the 2009 Clinical Research Excellence Awards in London on October 20.
A pre-clinical study led by scientists at Cincinnati Children's demonstrates that in mice the drug barasertib reverses the activation of fibroblasts that cause dangerous scar tissue to build up in the lungs of people with idiopathic pulmonary fibrosis (IPF).
The U.S. Food and Drug Administration today announced the launch of a collaborative study with the National Eye Institute and the U.S. Department of Defense to examine the potential impact on quality of life from Laser-Assisted In Situ Keratomileusis (LASIK), a surgical procedure that uses an eximer laser to permanently change the shape of the cornea.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Marlowe, 358 W Main St, Avon, CT 06001-3643 Ph: (866) 389-2727 | Mary Marlowe, 358 W Main St, Avon, CT 06001-3643 Ph: (866) 389-2727 |
News Archive
Katherine Radek, PhD, of Loyola University Chicago Stritch School of Medicine, has received a prestigious Presidential Early Career Award for Scientists and Engineers.
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
INC Research®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, is pleased to announce that Trusted Process® thought leaders at INC Research were named winners at the 2009 Clinical Research Excellence Awards in London on October 20.
A pre-clinical study led by scientists at Cincinnati Children's demonstrates that in mice the drug barasertib reverses the activation of fibroblasts that cause dangerous scar tissue to build up in the lungs of people with idiopathic pulmonary fibrosis (IPF).
The U.S. Food and Drug Administration today announced the launch of a collaborative study with the National Eye Institute and the U.S. Department of Defense to examine the potential impact on quality of life from Laser-Assisted In Situ Keratomileusis (LASIK), a surgical procedure that uses an eximer laser to permanently change the shape of the cornea.
› Verified 1 days ago
Sasha Perry, PMHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-284-0182 | |
Deborah L Collins-perrica, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-284-0182 Fax: 860-284-6804 | |
Latonya Sheriee King, PMHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 152 Simsbury Rd Bldg 9, Avon, CT 06001 Phone: 802-565-1755 Fax: 860-650-1920 | |
Courtney Streeto, APRN Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-284-0182 | |
Marjorie Arni, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-674-2691 Fax: 860-677-6443 | |
Mr. David Yarbrough, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 385 W Main St, Avon, CT 06001 Phone: 860-777-1280 | |
Debra Anne Gage, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 80 Fisher Drive, Hartford Hospital Cancer Center, Avon, CT 06001 Phone: 860-674-0088 |